| Income Statement |
| Total Revenue | 2.83M |
|
| Revenues (USD) | 2.83M |
| Cost of Revenue | 2.62M |
| Gross Profit | 210.00K |
| Operating Expenses | 13.44M |
| Research and Development Expense | 7.67M |
| Selling, General and Administrative Expense | 6.18M |
| Operating Income | -13.23M |
| Net Income | -11.74M |
| Net Income Common Stock | -11.74M |
| Net Income Common Stock (USD) | -11.74M |
| Consolidated Income | -11.74M |
| Earnings per Basic Share | -0.07 |
| Earnings per Basic Share (USD) | -0.07 |
| Earnings per Diluted Share | -0.07 |
| Earning Before Interest & Taxes (EBIT) | -11.74M |
| Earning Before Interest & Taxes (USD) | -11.74M |
| Weighted Average Shares | 177.67M |
| Weighted Average Shares Diluted | 177.67M |
| Balance Sheet |
| Cash and Equivalents | 20.26M |
| Cash and Equivalents (USD) | 20.26M |
| Investments | 119.07M |
| Investments Current | 52.21M |
| Investments Non-Current | 66.86M |
| Trade and Non-Trade Receivables | 3.03M |
| Current Assets | 81.45M |
| Property, Plant & Equipment Net | 41.46M |
| Total Assets | 190.75M |
| Debt Current | 2.80M |
| Total Debt | 3.72M |
| Current Liabilities | 8.07M |
| Debt Non-Current | 912.00K |
| Total Liabilities | 9.03M |
| Accumulated Retained Earnings (Deficit) | -218.74M |
| Shareholders Equity | 181.72M |
| Shareholders Equity (USD) | 181.72M |
| Assets Non-Current | 109.31M |
| Total Debt (USD) | 3.72M |
| Inventory | 1.92M |
| Liabilities Non-Current | 953.00K |
| Trade and Non-Trade Payables | 901.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 2.61M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.68M |
| Capital Expenditure | -276.00K |
| Net Cash Flow from Investing | 10.05M |
| Net Cash Flow - Investment Acquisitions and Disposals | 10.33M |
| Net Cash Flow from Operations | -12.73M |
| Share Based Compensation | 1.45M |